Literature DB >> 20814950

Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24.

Zahid Ahmad1, Elaine Zackai, Livija Medne, Abhimanyu Garg.   

Abstract

Mandibuloacral dysplasia (MAD) is an autosomal recessive disorder characterized by hypoplasia of the mandible and clavicles, acro-osteolysis, and lipodystrophy due to mutations in LMNA or ZMPSTE24. Only six MAD patients are reported so far with ZMPSTE24 mutations and limited phenotypic data are available for them. Here, we report on two brothers (4 years and 9-month old) with early onset MAD due to ZMPSTE24 mutations in whom thin skin was noted as early as 5 months of age. Both had micrognathia, mottled hyperpigmentation, and enlarged fontanelles but little evidence of lipodystrophy. There was no delay of mental development. The older brother had small pinched nose, short clavicles, acro-osteolysis, stunted growth, joint stiffness, and repeated fractures. There was no evidence of renal disease. Both patients were compound heterozygotes harboring a previously reported missense ZMPSTE24 mutation, p.Pro248Leu, and a novel null mutation, p.Trp450stop. These patients and the review of literature reveal that compared to MAD patients with LMNA mutations, those with ZMPSTE24 mutations develop manifestations earlier in life. Other distinguishing features in MAD due to ZMPSTE24 mutations may include premature birth, renal disease, calcified skin nodules, and lack of acanthosis nigricans. We conclude that in patients with MAD due to ZMPSTE24 mutations, the onset of disease manifestations such as thin skin and micrognathia occurs as early as 5 months of age. In these patients, skeletal phenotype presents earlier whereas lipodystrophy and renal disease may occur later in life.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814950      PMCID: PMC2965306          DOI: 10.1002/ajmg.a.33664

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  42 in total

1.  Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature.

Authors:  Robert Smigiel; Aleksandra Jakubiak; Vera Esteves-Vieira; Katarzyna Szela; Agnieszka Halon; Tomasz Jurek; Nicolas Lévy; Annachiara De Sandre-Giovannoli
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

2.  Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation.

Authors:  Elizabeth McPherson; Lesley Turner; Ivan Zador; Kara Reynolds; David Macgregor; Philip F Giampietro
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

3.  Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging.

Authors:  Ignacio Varela; Sandrine Pereira; Alejandro P Ugalde; Claire L Navarro; María F Suárez; Pierre Cau; Juan Cadiñanos; Fernando G Osorio; Nicolas Foray; Juan Cobo; Félix de Carlos; Nicolas Lévy; José M P Freije; Carlos López-Otín
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

4.  Mandibuloacral dysplasia type A in childhood.

Authors:  L Garavelli; M R D'Apice; F Rivieri; M Bertoli; A Wischmeijer; C Gelmini; V De Nigris; E Albertini; S Rosato; R Virdis; E Bacchini; R Dal Zotto; G Banchini; L Iughetti; S Bernasconi; A Superti-Furga; G Novelli
Journal:  Am J Med Genet A       Date:  2009-10       Impact factor: 2.802

5.  Novel LMNA mutation in atypical Werner syndrome presenting with ischemic disease.

Authors:  Dimitri Renard; Genevieve Fourcade; Didier Milhaud; Didier Bessis; Vera Esteves-Vieira; Amandine Boyer; Patrice Roll; Patrice Bourgeois; Nicolas Levy; Annachiara De Sandre-Giovannoli
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

6.  Progeroid syndrome with scleroderma-like skin changes associated with homozygous R435C LMNA mutation.

Authors:  Agnieszka Madej-Pilarczyk; Danuta Rosińska-Borkowska; Joanna Rekawek; Michał Marchel; Ewa Szaluś; Stefania Jabłońska; Irena Hausmanowa-Petrusewicz
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

7.  Atypical progeroid syndrome due to heterozygous missense LMNA mutations.

Authors:  Abhimanyu Garg; Lalitha Subramanyam; Anil K Agarwal; Vinaya Simha; Benjamin Levine; Maria Rosaria D'Apice; Giuseppe Novelli; Yanick Crow
Journal:  J Clin Endocrinol Metab       Date:  2009-10-29       Impact factor: 5.958

8.  Severe mandibuloacral dysplasia-associated lipodystrophy and progeria in a young girl with a novel homozygous Arg527Cys LMNA mutation.

Authors:  Anil K Agarwal; Irina Kazachkova; Svetlana Ten; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2008-09-16       Impact factor: 5.958

Review 9.  Restrictive dermopathy--a lethal congenital laminopathy. Case report and review of the literature.

Authors:  Paulo Morais; Sofia Magina; Maria do Céu Ribeiro; Manuela Rodrigues; José Manuel Lopes; Huong Le Thi Thanh; Manfred Wehnert; Hercília Guimarães
Journal:  Eur J Pediatr       Date:  2008-11-20       Impact factor: 3.183

10.  Novel LMNA gene mutation in a patient with Atypical Werner's Syndrome.

Authors:  Yun Jeong Doh; Hee Kyoung Kim; Eui Dal Jung; Seung Hee Choi; Jung Guk Kim; Bo Wan Kim; In Kyu Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 2.884

View more
  19 in total

Review 1.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

2.  Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.

Authors:  Jemima Barrowman; Patricia A Wiley; Sarah E Hudon-Miller; Christine A Hrycyna; Susan Michaelis
Journal:  Hum Mol Genet       Date:  2012-06-19       Impact factor: 6.150

3.  Homozygous null mutations in ZMPSTE24 in restrictive dermopathy: evidence of genetic heterogeneity.

Authors:  Z Ahmad; S R Phadke; E Arch; J Glass; A K Agarwal; A Garg
Journal:  Clin Genet       Date:  2010-11-25       Impact factor: 4.438

4.  A novel syndrome of mandibular hypoplasia, deafness, and progeroid features associated with lipodystrophy, undescended testes, and male hypogonadism.

Authors:  Savitha Shastry; Vinaya Simha; Koumudi Godbole; Paolo Sbraccia; Serge Melancon; Chittaranjan S Yajnik; Giuseppe Novelli; Matthias Kroiss; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

Review 5.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

6.  New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.

Authors:  Claire Laure Navarro; Vera Esteves-Vieira; Sébastien Courrier; Amandine Boyer; Thuy Duong Nguyen; Le Thi Thanh Huong; Peter Meinke; Winnie Schröder; Valérie Cormier-Daire; Yves Sznajer; David J Amor; Kristina Lagerstedt; Martine Biervliet; Peter C van den Akker; Pierre Cau; Patrice Roll; Nicolas Lévy; Catherine Badens; Manfred Wehnert; Annachiara De Sandre-Giovannoli
Journal:  Eur J Hum Genet       Date:  2013-10-30       Impact factor: 4.246

7.  Phenotypic heterogeneity of ZMPSTE24 deficiency.

Authors:  Thomas A Cassini; Amy K Robertson; Anna G Bican; Joy D Cogan; Vickie L Hannig; John H Newman; Rizwan Hamid; John A Phillips
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

8.  Hallermann-Streiff Syndrome: No Evidence for a Link to Laminopathies.

Authors:  F Kortüm; M Chyrek; S Fuchs; B Albrecht; G Gillessen-Kaesbach; U Mütze; E Seemanova; S Tinschert; D Wieczorek; G Rosenberger; K Kutsche
Journal:  Mol Syndromol       Date:  2011-11-12

Review 9.  Mechanisms of vascular calcification in CKD-evidence for premature ageing?

Authors:  Catherine M Shanahan
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

10.  Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China.

Authors:  Di-Qing Luo; Xiao-Zhu Wang; Yan Meng; Ding-Yang He; Ying-Ming Chen; Zhi-Yong Ke; Ming Yan; Yu Huang; Da-Fang Chen
Journal:  BMC Pediatr       Date:  2014-10-07       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.